FDA Moves to Reevaluate Several Peptides American Med Spa Association FDA takes first step in possible reversal of ban on some peptides The Washington Post BREAKING: The FDA just reversed their 2023 peptide ban. 12 peptides pulled from the Category 2 restricted list: 1. BPC 157 2. Thymosin beta 4 fragment (TB 500) 3. Epitalon 4. GHK Cu 5. MOTS C 6. BPC 157 & TB 500 Peptide Therapy for Injury Recovery Sanctuary Wellness